SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-22-000048
Filing Date
2022-05-16
Accepted
2022-05-16 06:04:19
Documents
47
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K phas-20220516.htm   iXBRL 8-K 38101
2 EX-99.1 phasebioq12022financialres.htm EX-99.1 56000
3 EX-99.2 phasebioq12022financials.htm EX-99.2 39052
7 phasebio2020logo.jpg GRAPHIC 27705
8 phasebioq12022financials001.jpg GRAPHIC 73096
9 phasebioq12022financials002.jpg GRAPHIC 249397
10 phasebioq12022financials003.jpg GRAPHIC 133578
11 phasebioq12022financials004.jpg GRAPHIC 123776
12 phasebioq12022financials005.jpg GRAPHIC 43469
13 phasebioq12022financials006.jpg GRAPHIC 136030
14 phasebioq12022financials007.jpg GRAPHIC 69527
15 phasebioq12022financials008.jpg GRAPHIC 52178
16 phasebioq12022financials009.jpg GRAPHIC 120519
17 phasebioq12022financials010.jpg GRAPHIC 121511
18 phasebioq12022financials011.jpg GRAPHIC 104923
19 phasebioq12022financials012.jpg GRAPHIC 43466
20 phasebioq12022financials013.jpg GRAPHIC 162807
21 phasebioq12022financials014.jpg GRAPHIC 140712
22 phasebioq12022financials015.jpg GRAPHIC 99828
23 phasebioq12022financials016.jpg GRAPHIC 74834
24 phasebioq12022financials017.jpg GRAPHIC 169831
25 phasebioq12022financials018.jpg GRAPHIC 146745
26 phasebioq12022financials019.jpg GRAPHIC 44924
27 phasebioq12022financials020.jpg GRAPHIC 140074
28 phasebioq12022financials021.jpg GRAPHIC 124430
29 phasebioq12022financials022.jpg GRAPHIC 107880
30 phasebioq12022financials023.jpg GRAPHIC 45003
31 phasebioq12022financials024.jpg GRAPHIC 140191
32 phasebioq12022financials025.jpg GRAPHIC 95248
33 phasebioq12022financials026.jpg GRAPHIC 100246
34 phasebioq12022financials027.jpg GRAPHIC 103297
35 phasebioq12022financials028.jpg GRAPHIC 56020
36 phasebioq12022financials029.jpg GRAPHIC 153160
37 phasebioq12022financials030.jpg GRAPHIC 102978
38 phasebioq12022financials031.jpg GRAPHIC 133185
39 phasebioq12022financials032.jpg GRAPHIC 138585
  Complete submission text file 0001169245-22-000048.txt   5236166

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phas-20220516.xsd EX-101.SCH 1902
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phas-20220516_lab.xml EX-101.LAB 25848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phas-20220516_pre.xml EX-101.PRE 13581
41 EXTRACTED XBRL INSTANCE DOCUMENT phas-20220516_htm.xml XML 11435
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 22925182
SIC: 2834 Pharmaceutical Preparations